T his issue of IJLEW will appear when the summer is here, although it's spring 2007 as I write this column for issue 6.2. IJLEW is now in its 6th year of publication. It receives a growing number of original articles as well as review and case reports, it also receives invited contributions in the form of Guest Editorial from leading scientists and clinicians dedicated to wound healing. I am going to spend a few minutes looking back along the way that we have just traversed during this period.
It occurs to me that there have been a few changes in the wound-healing scene during this period of which the most significant is the growing acceptance that the prevalence of diabetes is growing worldwide. It follows that some complications of diabetes such as peripheral arterial disease that leads to diabetic foot disease will also increase. This increase may be attributed simply to being more vigilant, better diagnostic capability, and increase in smoking habits. It is clear that in such large populations as exists in India, smoking is increasing and this will compound matters. It is estimated that in India alone, there will be 60 million feet at risk in a decade! During this period, we have learned with some exceptions, the healing potential of growth factors is unlikely to be fulfilled. We have read that certain plant products are safe and effective when studied on wound models. We have learned about the value of education and training in wound healing, and witnessed the development of several guidelines. So how do we optimally plan wound care for these patients?
It seems to me that pathways and guidelines are very important, as indeed are audits to check that these are practical and that we follow them. A need that is key to developing a strategy is to identify and study the healing potential in clinical terms of products that are widely available, bearing in mind that a cure is only as good as it is available. Bench scientists work overtime to develop and test the safety of new devices and products. When some of these fail to meet the promise, both bench scientists and clinician scientists should tackle problems together. This togetherness is dependent on having good communications or a conduit. This conduit must be kept open at all times and used to promote wound science and therefore healing.
Another change is the awareness that problems with chronic wounds exist and that we can do something in certain areas. While these messages can and do filter through such journals as IJLEW, learned societies also play an important role in this direction. With the advent of spring, the new cycle of meetings will commence. This year all the major European wound healing events are being held in the United Kingdom, for example, EWMA in Glasgow, EPUAP in Oxford, and the ETRS in Southampton, and there are others. I am quietly confident that these will lead us in the right directions.
